RANdOM · Systematic search of RegulAtory elements coNtrOlling autosomal Monoallelic expression
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2018-01-01 → 2022-04-01
- Финансиране от ЕС
- 248 063 €
- Участници
- 2
- Схема
- MSCA-IF-GF
Линиите свързват координатора с партньорите.
Накратко на български
Генната експресия понякога е моноалелна, което означава, че клетката използва само едната копия на даден ген, вместо и двете. Разбирането на този механизъм помага да се разбере как нарушаването му може да доведе до развитие на заболявания.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Systematic search of RegulAtory elements coNtrOlling autosomal Monoallelic expression
The establishment and maintenance of the epigenetic states that define cell identity are fundamental processes in metazoan biology. By crystallizing gene expression regulatory states in cell populations, permanently or transiently, these mechanisms set the foundations of embryonic development, cell differentiation, and tissue homeostasis. Among the diverse epigenetic phenomena, perhaps one of the most intriguing is the process of gene expression regulation that results in biases of allelic expression, sometimes with the complete silencing of one of the alleles (monoallelic expression). This is because the silencing of one of the two copies of a gene in a diploid genome potentially abolishes the benefits of a redundant genome. Monoallelic expression is also intriguing because it reveals the asymmetric regulation of two genetic entities (the two alleles of the same gene) that are otherwise identical. This project aims at better understand the mitotically stable random monoallelic expression (RME) and random imbalanced expression (RIE) that is observed on a fraction of the autosomal genes. Although it is estimated that only 1-10% of the autosomes show such an expression pattern, the widespread of functional classes observed among the affected genes underlies diverse pathways and emphasizes the potential for disease consequent from the perturbation of RME and RIE regulation. Indeed, great focus has been given to the role of allelic-specific cis-regulatory genetic effects on disease, but these studies are insensitive to the random allelic effects of epigenetic nature, either because these are canceled out (e.g., RNA-Seq studies in bulk tissues), the technology is not (yet) sensitive enough to reliably call mitotically-stable epigenetic allelic biases (single-cell RNA-Seq), or are not high-throughput (e.g., FISH) and thus lack power. As a consequence, the impact of allelic imbalances of epigenetic nature on disease remains uncertain. The overall objective of this action is to identify mechanisms of regulation of mitotically stable allelic imbalances in murine cells. Additionally, we will characterize the dynamics of allele-specific expression along the cell cycle progression and characterize for the first time the highly stable monoallelic expression states in hematopoietic stem cells in the mouse model, in vivo. These studies will consolidate the base knowledge in the field and set the ground for the introduction of the clonal parameter on studies of functional genetics.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Autosomal monoallelic expression (MAE) is an epigenetic phenomenon that controls the relative expression of maternal and paternal alleles in thousands of mammalian genes. Despite MAE’s widespread character the molecular mechanisms involved in its establishment and maintenance are yet to be clarified. Recent work shows that the sets of genes subject to MAE are highly consistent across individuals and conserved between human and mouse species. I propose to test that such conservation is due to specific regulatory elements in the genome associated with MAE genes. The strategy to discover such elements is via a systematic analysis of differences in genome-wide MAE patterns. In the outgoing phase of the Fellowship, I will be based in DFCI under the supervision of Prof. A. Gimelbrant. There, I will experimentally map MAE patterns in mice with highly divergent genomic backgrounds and identify loci that consistently differ between strains in whether they are MAE. Using computational methods, I will then determine whether particular motifs are associated with such variable regions. I will further assess the role of the candidate regulatory elements using specific F1 crosses and targeted mutagenesis. The analysis in the mouse will be complemented by comparative analysis of human and chimp matched cells, in order to narrow down the candidate loci list and shed light on the evolution of MAE. Successful completion of this project will establish the first model of genetic control of MAE and open doors to progress in the mechanistic and developmental understanding of MAE. On return to the TCD, under the supervision of Prof. A. McLysaght, I will be the link between two laboratories with a diverse research focus that would not be collaborating unless in the context of this Fellowship. I will emerge from this collaborative work with new skills commensurate with a leading independent researcher in the EU.
Оригинален текст от CORDIS (на английски).
Участници
- THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN · DublinКоординаторИрландия
- DANA-FARBER CANCER INSTITUTE INC · Boston MaСъединени щати
Връзки
Данни: CORDIS, © Европейски съюз
